Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.860
-0.040 (-2.11%)
At close: Aug 17, 2026, 4:00 PM EDT
1.950
+0.090 (4.84%)
Pre-market: Aug 18, 2026, 8:04 AM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $17.45 million as of August 18, 2026. Its market cap has decreased by -92.25% in one year.
Market Cap
17.45M
Enterprise Value
1.83M
1-Year Change
-92.25%
Ranking
Category
Stock Price
$1.86
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $17.45M, a decrease of -89.78%. That is a compound annual growth rate of -81.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 17.45M | -56.74% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 19.67M |
| Marker Therapeutics | 19.01M |
| NewcelX | 18.01M |
| Skye Bioscience | 17.62M |
| KALA BIO | 17.58M |
| Cyclerion Therapeutics | 17.46M |
| Palatin Technologies | 17.44M |
| Lipocine | 17.40M |